A method to generate mature dendritic cells from cryopreserved PBMC
Tóm tắt
Objective: To established methods for cryopreserving peripheral blood mononuclear cells (PBMCs) and producing DCs from cryopreserved PBMCs. Methods: Mature DCs were generated from cryopreserved PBMCs by using IL-4, GM-CSF, TNF-α, IL-1β, IL-6, pgE2 and LPS. The phenotype of the resultant DCs was investigated by flow cytometry. The functions of the resultant DCs were verified by Elispot assay. Results: The resultant DCs expressed high levels of HLA ABC, HLA DR, costimulatory molecules and the DC maturation marker CD83. The mature DCs we generated from frozen PBMCs were able to prime CD8 T cells into long term IFN-γ producing peptide specific CTL. Conclusion: The DCs we developed from cryopreserved PBMC were fully mature and had the capability to stimulate immune reaction. Thus, we developed a method to generate functional mature DC from cryopreserved PBMC.
Tài liệu tham khảo
Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines [J]. Cell 2001; 106:255.
Heimberger AB, Archer GE, Crotty LE, et al. Dendritic cells pulsed with a tumor-specific peptide induce long-lasting immunity and are effective against murine intracerebral melanoma [J]. Neurosurgery 2002; 50:158.
Mullins DW, Bullock TN, Colella TA, et al. Immune responses to the HLA-A*0201-restricted epitopes of tyrosinase and glycoprotein 100 enable control of melanoma outgrowth in HLA-A*0201-transgenic mice [J]. J Immunol 2001; 167:4853.
Alters SE, Gadea JR, Sorich M, et al. Dendritic cells pulsed with CEA peptide induce CEA-specific CTL with restricted TCR repertoire [J]. J Immunother 1998; 21:17.
Tjoa BA, Erickson SJ, Bowes VA, et al. Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides [J]. Prostate 1997; 32:272.
Gatz SA, Pohla H, Schendel DJ. A PCR-SSP method to specifically select HLA-A*0201 individuals for immunotherapeutic studies [J]. Tissue Antigens 2000; 55:532.
Schnurr M, Galambos P, Scholz C, et al. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines [J]. Cancer Res 2001; 61:6445.
Schmitt WE, Stassar MJ, Schmitt W, et al. In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells [J]. J Cancer Res Clin Oncol 2001; 127:203.
Garlie NK, Siebenlist RE, Lefever AV. T cells activated in vitro as immunotherapy for renal cell carcinoma: characterization of 2 effector T-cell populations [J]. J Urol 2001; 166:299.
Ni HT, Spellman SR, Jean WC, et al. Immunization with dendritic cells pulsed with tumor extract increases Survival of mice bearing intracranial gliomas [J]. J Neurooncol 2001; 51:1.
Banchereau J, Schuler-Thurner B, Palucka AK, et al. Dendritic cells as vectors for therapy [J]. Cell 2001; 106:271.
Lapointe R, Toso JF, Butts C, et al. Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes [J]. Eur J Immunol 2000; 30:3291.